VU6015929是一种高效、选择性且具有口服活性的双 Discoidin 域受体 1/2 (DDR1/2) 抑制剂，其 IC50 值分别为 4.67 nM 和 7.39 nM，能够强效阻断胶原诱导的 DDR1 活化及胶原 IV 的生成。

DDR1-IN-1是一种强效且选择性的DDR1受体酪氨酸激酶抑制剂，IC50/EC50分别为105 nM/87 nM，对DDR2的抑制作用较弱（IC50= 413 nM）。

7rh是一种具有IC50为13.1 nM的 discoidin 域受体1（DDR1）抑制剂，对DDR2的IC50为203 nM。

FGFR1/DDR2 inhibitor 1是一种双重靶向FGFR1和DDR2的抑制剂，展现了抗肿瘤活性，对多种肿瘤研究具有潜力。

ODM-203是一种选择性的FGFR和VEGFR抑制剂，IC50分别为：对重组FGFR1-4为11, 16, 6, 35 nM，对VEGFR1-3为26, 9, 5 nM。

BAY-826 is a selective and potent TIE-2 inhibitor with Kdof 1.6 nM, respectively.

LY2801653 2HCl is a potent, orally bioavailable, small-molecule inhibitor of c-MET kinase (Ki= 2 nM).

DDR1-IN-5 is a selective Discoidin Domain Receptor family, member 1 (DDR1) inhibitor with an IC50 of 7.36 nM. DDR1-IN-5 inhibits auto-phosphorylation DDR1b (Y513) with an IC50 of 4.1 nM. DDR1-IN-5 has anti-cancer activity[1].

DDR1-IN-6 is a selective Discoidin Domain Receptor family, member 1 (DDR1) inhibitor with an IC50 of 9.72 nM. DDR1-IN-6 inhibits auto-phosphorylation DDR1b (Y513) with an IC50 of 9.7 nM. DDR1-IN-6 has anti-cancer activity[1].

WRG-28 is a selective allosteric inhibitor of DDR2 with IC50 of 230 nM.

DDR Inhibitor is a potent discoidin domain receptor (DDR) inhibitor, with an IC50 of 3.3 nM for DDR2, and shows 53% inhibition on DDR1 at 1.5 nM.

ML 786 2HCl is a potent Raf kinase inhibitor with IC50s of 2.1, 2.5 and 4.2 nM for B-RafV600E, C-Raf and wild-type B-Raf, respectively.